Long Focus Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Long Focus Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-248,099	Closed	-$561K	–	95
2025 Q2	$561K	Hold	248,099	–	–	0.02%	91
2025 Q1	$662K	Hold	248,099	–	–	0.02%	96
2024 Q4	$873K	Hold	248,099	–	–	0.03%	94
2024 Q3	$1.18M	Hold	248,099	–	–	0.04%	85
2024 Q2	$1.17M	Hold	248,099	–	–	0.04%	84
2024 Q1	$1.13M	Hold	248,099	–	–	0.06%	80
2023 Q4	$1.02M	Hold	248,099	–	–	0.03%	87
2023 Q3	$1.07M	Hold	248,099	–	–	0.04%	86
2023 Q2	$1.29M	Sell	248,099 -65,121	-21%	-$457K	0.06%	81
2023 Q1	$2.13M	Hold	313,220	–	–	0.12%	69
2022 Q4	$767K	Buy	313,220 +5,000	+2%	+$12.8K	0.05%	86
2022 Q3	$1.02M	Buy	308,220 +130,624	+74%	+$623K	0.1%	74
2022 Q2	$867K	Buy	177,596 +117,596	+196%	+$798K	0.09%	80
2022 Q1	$454K	Hold	60,000	–	–	0.06%	90
2021 Q4	$467K	Buy	+60,000	New	+$471K	0.06%	87

Other funds holding ACHV

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Long Focus Capital Management's ACHV Position: Q3 2025 in Review

Long Focus Capital Management sold out of Achieve Life Sciences (ACHV) in Q3 2025, closing a stake of 248,099 shares — an estimated $561K sold.

Long Focus Capital Management first reported a position in ACHV in Q4 2021 and held it in 15 quarters. The position peaked at $2.13M in Q1 2023. 66 funds tracked by Wall St. Rank hold ACHV as of Q3 2025.

Long Focus Capital Management reported no remaining Achieve Life Sciences position as of Q3 2025 after selling out during the quarter.
Long Focus Capital Management sold 248,099 Achieve Life Sciences shares in Q3 2025, an estimated $561K.
Long Focus Capital Management first reported a position in Achieve Life Sciences in Q4 2021 and held it in 15 quarters.
Long Focus Capital Management's Achieve Life Sciences position peaked at $2.13M in Q1 2023.
66 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2025.

Based on Long Focus Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.